+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protopic"

Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Atopic Dermatitis Drugs Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
From
From
Protopic - API Insight, 2022 - Product Thumbnail Image

Protopic - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Protopic- Drug Insight, 2019 - Product Thumbnail Image

Protopic- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Protopic is a topical immunomodulator used to treat immune disorders such as atopic dermatitis, also known as eczema. It is a calcineurin inhibitor, which works by suppressing the body's immune response to reduce inflammation and itching. Protopic is available in both ointment and cream forms, and is typically applied twice daily. It is generally used as a short-term treatment, and is not recommended for long-term use due to potential side effects. Protopic is a relatively new drug, and is one of the few topical treatments available for immune disorders. It is often used as an alternative to systemic immunosuppressants, which can have more serious side effects. Protopic is generally well-tolerated, and is considered a safe and effective treatment for atopic dermatitis. Some companies in the Protopic market include Novartis, Pfizer, and GlaxoSmithKline. These companies produce and market Protopic, as well as other topical treatments for immune disorders. Show Less Read more